Search

This report describes epidemiological and virological surveillance results for the influenza season of 2022–2023 in Sweden. Data are also compared to previous influenza seasons.

On this page you find a table showing how the Swedish vaccination programme for children has evolved over the years.

In Sweden, children are offered protection against eleven diseases through the national vaccination programme for children. The vaccination programme for persons at risk includes vaccinations against pneumococcal infections.

This report describes epidemiological and virological surveillance results for the 2023-2024 influenza season in Sweden. Data are also compared to previous influenza seasons.

Information about the Public Health Agency's regulations FoHMFS 2014:3 on exceptions to the requirement for a permit in accordance with the Prohibition of Certain Goods Dangerous to Health Act (SFS 1999:42). The regulations only concern gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).

This is a variable list of the variables contained in the National Vaccination Register (NVR). NVR is a register of reported vaccinations administered within the scope of the national vaccination programme for children, vaccination programme against pneumococcal infections for risk groups and the

To be able to check whether a tobacco product is authentic or not, the unit packet must carry a tamper proof security feature, with visible and invisible elements. Cigarettes and roll-your-own tobacco supplied to consumers in Sweden must have a safety feature with at least five authentication

This report describes the monitoring and surveillance systems for influenza in use during the 2024–2025 winter season and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons. See also the tables and figures section as well as the

Smoking is unevenly distributed in the population, and there are significant differences between various groups based on education, income, and employment. The use of nicotine pouches and e-cigarettes is increasing among the population and is most common among individuals aged 16–29 years.

In order to identify antibiotic products that are particularly valuable for the Swedish healthcare, the Public Health Authority, in collaboration with PLATINEA and an external reference group, has carried out a clinical evaluation of antibiotic products based on their substance, formulation and